These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 37958292)
1. The Immunological Landscape of M1 and M2 Macrophages and Their Spatial Distribution in Patients with Malignant Pleural Mesothelioma. Laberiano-Fernandez C; Baldavira CM; Machado-Rugolo J; Tamegnon A; Pandurengan RK; Ab'Saber AM; Balancin ML; Takagaki TY; Nagai MA; Capelozzi VL; Parra ER Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958292 [TBL] [Abstract][Full Text] [Related]
2. Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma. Cornelissen R; Lievense LA; Maat AP; Hendriks RW; Hoogsteden HC; Bogers AJ; Hegmans JP; Aerts JG PLoS One; 2014; 9(9):e106742. PubMed ID: 25192022 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry. Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162 [TBL] [Abstract][Full Text] [Related]
4. A new method for predicting the prognosis of colorectal cancer patients through a combination of multiple tumor-associated macrophage markers at the invasive front. Wang X; Yuwen TJ; Zhong Y; Li ZG; Wang XY Heliyon; 2023 Feb; 9(2):e13211. PubMed ID: 36798759 [TBL] [Abstract][Full Text] [Related]
5. The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers. Ujiie H; Kadota K; Nitadori JI; Aerts JG; Woo KM; Sima CS; Travis WD; Jones DR; Krug LM; Adusumilli PS Oncoimmunology; 2015 Jun; 4(6):e1009285. PubMed ID: 26155428 [TBL] [Abstract][Full Text] [Related]
6. Exploratory study of macrophage polarization and spatial distribution in colorectal cancer liver metastasis: a pilot study. Khanduri I; Maru DM; Parra ER Front Immunol; 2023; 14():1223864. PubMed ID: 37637998 [TBL] [Abstract][Full Text] [Related]
7. CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis. Olmes G; Büttner-Herold M; Ferrazzi F; Distel L; Amann K; Daniel C Arthritis Res Ther; 2016 Apr; 18():90. PubMed ID: 27091114 [TBL] [Abstract][Full Text] [Related]
8. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers. Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648 [TBL] [Abstract][Full Text] [Related]
9. Mesothelin expression remodeled the immune-matrix tumor microenvironment predicting the risk of death in patients with malignant pleural mesothelioma. Qualiotto AN; Baldavira CM; Balancin M; Ab'Saber A; Takagaki T; Capelozzi VL Front Immunol; 2023; 14():1268927. PubMed ID: 37901248 [TBL] [Abstract][Full Text] [Related]
10. Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues. Parra ER; Zhai J; Tamegnon A; Zhou N; Pandurengan RK; Barreto C; Jiang M; Rice DC; Creasy C; Vaporciyan AA; Hofstetter WL; Tsao AS; Wistuba II; Sepesi B; Haymaker C Sci Rep; 2021 Feb; 11(1):4530. PubMed ID: 33633208 [TBL] [Abstract][Full Text] [Related]
11. Macrophage populations show an M1-to-M2 transition in an experimental model of coronal pulp tissue engineering with mesenchymal stem cells. Gu B; Kaneko T; Zaw SYM; Sone PP; Murano H; Sueyama Y; Zaw ZCT; Okiji T Int Endod J; 2019 Apr; 52(4):504-514. PubMed ID: 30387178 [TBL] [Abstract][Full Text] [Related]
12. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model. Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737 [TBL] [Abstract][Full Text] [Related]
14. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients. Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392 [TBL] [Abstract][Full Text] [Related]
15. CCL22-Polarized TAMs to M2a Macrophages in Cervical Cancer In Vitro Model. Wang Q; Sudan K; Schmoeckel E; Kost BP; Kuhn C; Vattai A; Vilsmaier T; Mahner S; Jeschke U; Heidegger HH Cells; 2022 Jun; 11(13):. PubMed ID: 35805111 [TBL] [Abstract][Full Text] [Related]
16. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma. Falleni M; Savi F; Tosi D; Agape E; Cerri A; Moneghini L; Bulfamante GP Melanoma Res; 2017 Jun; 27(3):200-210. PubMed ID: 28272106 [TBL] [Abstract][Full Text] [Related]
17. Type 2 Endometrial Cancer is Associated With a High Density of Tumor-Associated Macrophages in the Stromal Compartment. Kelly MG; Francisco AM; Cimic A; Wofford A; Fitzgerald NC; Yu J; Taylor RN Reprod Sci; 2015 Aug; 22(8):948-53. PubMed ID: 25701837 [TBL] [Abstract][Full Text] [Related]
18. Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma. Burt BM; Rodig SJ; Tilleman TR; Elbardissi AW; Bueno R; Sugarbaker DJ Cancer; 2011 Nov; 117(22):5234-44. PubMed ID: 21523763 [TBL] [Abstract][Full Text] [Related]